Why a Promising ALS Drug Failed: Emory Study Offers Answers
September 05, 2025
September 05, 2025
ATLANTA, Georgia, Sept. 5 (TNSjou) -- Emory University issued the following news release:
* * *
Why a promising ALS drug failed: Emory study offers answers
Findings reveal drug reached the spinal cord and brain but did not stop disease drivers, underscoring need for better biomarkers.
*
A new Emory University study (https://www.cell.com/cell/fulltext/S0092-8674(25)00908-0), led by the Emory ALS Center and the Center for Neurodegene . . .
* * *
Why a promising ALS drug failed: Emory study offers answers
Findings reveal drug reached the spinal cord and brain but did not stop disease drivers, underscoring need for better biomarkers.
*
A new Emory University study (https://www.cell.com/cell/fulltext/S0092-8674(25)00908-0), led by the Emory ALS Center and the Center for Neurodegene . . .